{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Aveanna Healthcare Holdings, Inc.
Aveanna Healthcare Hits Day Low of $7.81 Amid Price Pressure
Aveanna Healthcare Holdings, Inc. faced a significant stock decline today, reaching an intraday low amid a challenging trading session. Despite recent setbacks, the company has shown strong annual performance compared to broader market indices. However, concerns about its financial health persist, particularly regarding profitability and debt levels.
Aveanna Healthcare Faces Weak Start with Significant Gap Down Amid Market Concerns
Aveanna Healthcare Holdings, Inc. experienced a notable decline in stock performance, opening with a significant loss. The company's market capitalization is around USD 1,725 million, with concerning financial metrics, including a negative return on equity and a complex debt-to-equity structure. Technical indicators show mixed signals regarding future performance.
Aveanna Healthcare Hits Day Low of $8.73 Amid Price Pressure
Aveanna Healthcare Holdings, Inc. faced a notable decline in stock value on October 22, 2025, reaching an intraday low. Despite recent gains, the company grapples with financial challenges, including a negative book value and a high debt-to-equity ratio, complicating its market position in the Pharmaceuticals & Biotechnology sector.
Aveanna Healthcare Faces Weak Start with 9.87% Gap Down Amid Market Concerns
Aveanna Healthcare Holdings, Inc. experienced a notable decline in its stock price today, contrasting with its recent monthly performance, which showed a significant gain. The company's technical indicators present a mixed outlook, while its financial metrics reveal a substantial market capitalization and a negative return on equity.
Aveanna Healthcare Reaches New 52-Week High of $9.82
Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 9.82 on October 15, 2025, reflecting a substantial increase over the past year. With a market capitalization of USD 1,725 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite facing challenges such as negative return on equity.
Aveanna Healthcare Holdings Hits New 52-Week High of $9.36
Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 9.36 on October 14, 2025, reflecting a substantial increase of 272.8% over the past year. The company, with a market capitalization of USD 1,725 million, operates in the Pharmaceuticals & Biotechnology sector and has a negative debt-to-equity ratio.
Aveanna Healthcare Holdings Hits New 52-Week High at $9.03
Aveanna Healthcare Holdings, Inc. has achieved a new 52-week high of USD 9.03, reflecting a substantial increase in stock performance over the past year. With a market capitalization of USD 1,725 million, the company operates in the Pharmaceuticals & Biotechnology sector, facing unique financial challenges.
Aveanna Healthcare Hits New 52-Week High of $8.79, Up 250%
Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 8.79 on September 26, 2025, reflecting a substantial increase in stock performance over the past year. The company, with a market cap of USD 1,725 million, faces challenges in its financial metrics while navigating the pharmaceuticals and biotechnology sector.
Is Aveanna Healthcare Holdings, Inc. technically bullish or bearish?
As of August 26, 2025, Aveanna Healthcare Holdings, Inc. is in a bullish trend supported by strong technical indicators, despite a bearish weekly RSI, with a year-to-date return of 85.12% compared to the S&P 500's 12.22%.
Is Aveanna Healthcare Holdings, Inc. overvalued or undervalued?
As of March 28, 2022, Aveanna Healthcare Holdings, Inc. is considered risky and overvalued with a high P/E ratio of 31.16 compared to its peers, despite outperforming the S&P 500 with a 59.92% return over the past year.
Aveanna Healthcare Hits New 52-Week High of $8.68, Surges 238.4%
Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 8.68 on September 18, 2025, reflecting a 238.4% increase over the past year. With a market capitalization of USD 1,725 million, the company operates in the Pharmaceuticals & Biotechnology industry, showcasing unique financial metrics.
Is Aveanna Healthcare Holdings, Inc. overvalued or undervalued?
As of March 28, 2022, Aveanna Healthcare Holdings, Inc. is considered risky and overvalued, with a P/E ratio of 25, a negative Price to Book Value of -10.74, and an EV to EBITDA of 11.90, indicating it is priced at a premium compared to peers like Pediatrix Medical Group and OPKO Health, despite a strong one-year return of 90.23% contrasted by recent negative monthly returns.
Is Aveanna Healthcare Holdings, Inc. technically bullish or bearish?
As of June 13, 2025, the trend is mildly bullish with positive daily moving averages and weekly RSI, but caution is advised due to a mildly bearish weekly MACD and mixed signals from Bollinger Bands.
What does Aveanna Healthcare Holdings, Inc. do?
Aveanna Healthcare Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $559 million and a net profit of $5 million. Its market cap is approximately $942.30 million, with a P/E ratio of 25.00 and a negative return on equity of -43.55%.
How big is Aveanna Healthcare Holdings, Inc.?
As of Jun 18, Aveanna Healthcare Holdings, Inc. has a market capitalization of 942.30 million and reported net sales of 2,093.07 million with a net profit of 5.44 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
